Cyrus Poonawalla Net Worth, Age, Family & Biography $20.6B Real Time Net Worth #70 in the world today

Avan Parvadiya — Mon, 17 Apr 2023 10:22:36 +0000

About Cyrus Poonawalla

Cyrus S. Poonawalla is a well-known Indian billionaire and prominent businessman who is well-known for his contributions to the pharmaceutical industry. The Cyrus Poonawalla Group, a leading biotech company with operations in a number of nations, has him as chairman and managing director. Cyrus established the biopharmaceutical and vaccine manufacturing company Serum Institute of India in 1966.

Under his administration, the organisation has developed to become one of the biggest immunisation makers on the planet, delivering over 1.5 billion portions of antibodies every year. Apart from his contributions to the pharmaceutical industry, Cyrus is also committed to charitable activity. He established the Poonawalla Foundation to improve access to healthcare and education for underprivileged communities.

Cyrus Poonawalla along with Zavaray, his younger brother, is engaged in running the horse racing as well as breeding industry.

Cyrus Poonawalla Education

Poonawalla, an Indian billionaire businessman, was born in 1945 in Pune, Maharashtra, India. Cyrus Poonawalla is the son of Soli Poonawalla, a well-known racehorse breeder. He finished his education in Pune and went on to study at a university in the United Kingdom. He finished his studies in accounting and finance at the University of Pune after earning a degree in commerce from Brihan Maharashtra College of Commerce in Pune.

Cyrus Poonawalla Career

Dr. Cyrus Poonawalla established the Serum Institute of India (SII) in 1966, which became a pivotal force in the development and production of vaccines. Within two years of its launch, SII introduced its first therapeutic anti-tetanus serum, followed by the production of the anti-tetanus vaccine. By 1974, SII introduced the DTP vaccine, which protected children against diphtheria, tetanus, and pertussis. The institute also developed an anti-snake-venom serum for snake bites in 1981.

In 1989, the Serum Institute of India (SII) started producing the M-Vac, a measles vaccine and quickly became the largest vaccine manufacturer in India within a year. By the 1980s, India achieved self-sufficiency for Tetanus, Diphtheria, and Whooping Cough vaccines due to SII’s production. In 1994, the World Health Organization (WHO) accredited SII to export vaccines from India, enabling the supply of high-quality vaccines to UN agencies such as UNICEF (United Nations Children’s Fund) and PAHO (Pan American Health Organization).

Cyrus Poonawalla Facts

Apart from his role at the Serum Institute, Cyrus S. Poonawalla is also involved in a diverse range of businesses. His company, the Cyrus Poonawalla Group, has interests in multiple industries including Poonawalla Aviation, which offers private jet charters to customers, and the Royal Western India Turf Club, which operates horse racing tracks in Mumbai and Pune. Poonawalla’s entrepreneurial spirit has led him to invest in a variety of ventures, demonstrating his ability to navigate different markets and industries.

Cyrus Poonawalla and Irina Bas attend the Hennessy Lunch for the Tasting of Hennessy Paradis Imperial at Beach Hotel on May 24, 2017 in Cap d’Antibes, France.